EUVIMEDEUVIMED entdecken
Multizentrische Studie

Defining the Appropriate Length of Antimicrobial Therapy for Skull Base Osteomyelitis

Monica Trent, Kathleen M Kelly, Donald Tan, Jonathan Korpon, Jacob B Hunter, Hamid R Djalilian iD, Edward C Kuan, Ashleigh A Halderman iD

The Laryngoscope · 2025-08 · 135 (8) · 2889-2900

DOI: 10.1002/lary.32113 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Laryngoscope, online erschienen am 19.03.2025. Verfasst von Monica Trent und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, University of California, Irvine, California, USA. Hauptthemen laut MEDLINE: Osteomyelitis, Skull Base, Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Skull base osteomyelitis (SBO) is a rare infection comprising either the lateral (LSBO), central (CSBO), or both lateral and central (BSBO) skull base. Due to its rarity, the optimal length of antimicrobial therapy (AMT) has not been well defined. Therefore, the purpose of this study was to identify factors that may influence outcomes of SBO and formulate clearer recommendations on AMT duration.

Methods

A multi‐institutional retrospective cohort study of SBO patients was conducted. Patient demographics, medical comorbidities, presenting symptoms, laboratory results, radiographic imaging, surgical treatment, culture results, length of follow‐up, and type, length, and number of AMT courses were collected.

Results

Sixty‐five patients were included. The average age was 66.5 years, and the average length of symptoms (LOS) prior to diagnosis was 3.74 months. The most common pathogen was Pseudomonas aeruginosa ( n = 23) followed by coagulase‐negative Staphylococcus species ( n = 15). The average length of IV AMT was 6.8 weeks, and the average total length of AMT (TLA) was 15.7 weeks. Positive fungal cultures were associated with longer TLA (22.6 vs. 13.7 weeks, p = 0.02) and a greater number of distinct courses of AMT (4.1 vs. 2.7, p = 0.01).

Conclusion

In this series, the average length of IV AMT was 6.8 weeks. The average TLA was 15.7 weeks, indicating that a minimum of 6 weeks of IV AMT followed by a prolonged course of oral AMT is necessary to treat most cases of SBO. Fungal involvement significantly impacts the duration of AMT. Clinical guidelines are needed to better define the management of this complex disease. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisSkull BaseAnti-Bacterial AgentsAnti-Infective AgentsHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeAged, 80 and overAdultTime Factors

Stichwörter der Autor:innen

antimicrobial therapyinfectionmalignant otitis externaosteomyelitisskull baes osteomyelitis

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, University of California, Irvine, California, USA.
  • Department of Otolaryngology Head and Neck Surgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.
  • Department of Otolaryngology Head and Neck Surgery, Southwestern Medical Center, University of Texas, Dallas, Texas, USA.
  • Department of Otolaryngology Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology Head and Neck Surgery, Westchester Medical Center Health Network, Valhalla, New York, USA.

ORCID-Profile: Hamid R Djalilian, Ashleigh A Halderman

Zitieren

APA

Trent, M., Kelly, K. M., Tan, D., Korpon, J., Hunter, J. B., Djalilian, H. R., Kuan, E. C., & Halderman, A. A. (2025). Defining the Appropriate Length of Antimicrobial Therapy for Skull Base Osteomyelitis. The Laryngoscope, 135(8), 2889-2900. https://doi.org/10.1002/lary.32113

Vancouver

Trent M, Kelly KM, Tan D, Korpon J, Hunter JB, Djalilian HR, et al. Defining the Appropriate Length of Antimicrobial Therapy for Skull Base Osteomyelitis. The Laryngoscope. 2025;135(8):2889-2900. doi:10.1002/lary.32113

BibTeX
@article{Trent2025,
  author = {Trent, Monica and Kelly, Kathleen M and Tan, Donald and Korpon, Jonathan and Hunter, Jacob B and Djalilian, Hamid R and Kuan, Edward C and Halderman, Ashleigh A},
  title = {Defining the Appropriate Length of Antimicrobial Therapy for Skull Base Osteomyelitis},
  journal = {The Laryngoscope},
  year = {2025},
  volume = {135},
  number = {8},
  pages = {2889--2900},
  doi = {10.1002/lary.32113}
}
Kostenlos starten →